Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DCWS23
|
|||
| Drug Name |
166Ho microspheres
|
|||
| Drug Type |
Radiopharmaceutical therapy agent
|
|||
| Indication | Neuroendocrine cancer [ICD-11: 2B72.1; ICD-9: 209] | Phase 2 | [1] | |
| Company |
Terumo
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02067988) Holmium-166-radioembolization in NET After Lutetium-177-dotatate; an Efficacy Study (HEPAR_Plus). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.